IGFBP2 and COVID-19: Liver cirrhosis and adiposity affect serum levels of IGFBP-2 (Figure 1b,c), and the exclusion of these patients showed that the serum IGFBP-2 levels of patients with severe COVID-19 were higher in comparison to those of patients with moderate disease and healthy controls.